Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wolters-kluwer-health/an-open-trial-of-interferon-alfa-recombinant-for-hepatitis-c-after-0PD934paCM
References (25)
-
B. Dousset, F. Conti, D. Houssin, Y. Calmus (1994)
Acute vanishing bile duct syndrome after interferon therapy for recurrent HCV infection in liver-transplant recipients.The New England journal of medicine, 330 16
-
M. Souza, E. Abdelhay, M. Silva, H. Diamond, A. Valente, D. Tabak, L. Bouzas, R. Ribeiro (1992)
Late marrow allograft rejection following alpha-interferon therapy for hepatitis in a patient with paroxysmal nocturnal hemoglobinuria.Bone marrow transplantation, 9 6
-
(1992)
Sugivama Y. Okada S. Kurai K. Akahane Y. Sueai 3 - Y, -
Koravik Koravik, Mayer Mayer, Pohanka Pohanka, Schwartz Schwartz, Traindl Traindl, Graf Graf, Smolen Smolen (1988)
Adverse effect of low‐dose prophylactic human recombinant interferon‐alpha treatment in renal transplant recipientsTransplantation, 45
-
R. Knodell, K. Ishak, W. Black, Thomas Chen, R. Craig, N. Kaplowitz, T. Kiernan, J. Wollman (1981)
Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitisHepatology, 1
-
C. Féray, M. Gigou, D. Samuel, V. Paradis, J. Wilber, Marie David, M. Urdea, M. Reynés, C. Bréchot, H. Bismuth (1994)
The course of hepatitis C virus infection after liver transplantationHepatology, 20
-
M. Alter, H. Margolis, K. Krawczyński, F. Judson, A. Mares, W. Alexander, Y. Pin, Joan Miller, M. Gerber, R. Sampliner, Emory Meeks, M. Beach (1993)
The Natural History of Community-Acquired Hepatitis C in the United StatesSurvey of Anesthesiology, 37
-
A. Slater, J. Klein, G. Sonnenfeld, L. Ogden, L. Gray (1992)
The effects of interferon-alpha/beta in a model of rat heart transplantation.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 11 5
-
H. Okamoto, Yasushi Sugiyama, Shunichi Okada, K. Kurai, Y. Akahane, Y. Sugai, Takeshi Tanaka, Koei Sato, F. Tsuda, Y. Miyakawa, M. Mayumi (1992)
Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources.The Journal of general virology, 73 ( Pt 3)
-
A. Tsubota, K. Chayama, K. Ikeda, A. Yasuji, I. Koida, S. Saitoh, M. Hashimoto, S. Iwasaki, M. Kobayashi, K. Hiromitsu (1994)
Factors predictive of response to interferon‐α therapy in hepatitis C virus infectionHepatology, 19
-
A. Jacobs, J. Levenson, D. Golde (1987)
Induction of acute corneal allograft rejection by alpha-2 interferon.The American journal of medicine, 82 1
-
J. Kovařík, Gert Mayer, E. Pohanka, M. Schwarz, O. Traindl, H. Graf, J. Smolen (1988)
ADVERSE EFFECT OF LOW‐DOSE PROPHYLACTIC HUMAN RECOMBINANT LEUKOCYTE INTERFERON‐ALPHA TREATMENT IN RENAL TRANSPLANT RECIPIENTS: Cytomegalovirus Infection Prophylaxis Leading to an Increased Incidence of Irreversible RejectionsTransplantation, 45
-
Féray Féray, Gigou Gigou, Samuel Samuel, Mishiro Mishiro, Reynes Reynes, Bismuth Bismuth (1995)
Bréchot C. Influence of the genotypes on the severity of recurrent liver disease after liver transplantationGastroenterology, 108
-
S. Lui, A. Ali, J. Grundy, O. Fernando, Paul Griffiths, Paul Sweny (1992)
Double-blind, placebo-controlled trial of human lymphoblastoid interferon prophylaxis of cytomegalovirus infection in renal transplant recipients.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 7 12
-
T. Wright, T. Wright, T. Wright, E. Donegan, E. Donegan, E. Donegan, H. Hsu, H. Hsu, H. Hsu, L. Ferrell, L. Ferrell, L. Ferrell, J. Lake, J. Lake, J. Lake, Michael Kim, Michael Kim, Michael Kim, C. Combs, C. Combs, C. Combs, S. Fennessy, S. Fennessy, S. Fennessy, J. Roberts, J. Roberts, J. Roberts, N. Ascher, N. Ascher, N. Ascher, H. Greenberg, H. Greenberg, H. Greenberg (1992)
Recurrent and acquired hepatitis C viral infection in liver transplant recipients.Gastroenterology, 103 1
-
D. Samuel, H. Bismuth, A. Bismuth, J. Arulnaden, D. Mathieu, M. Reynés, J. Benhamou, C. Bréchot (1991)
Passive immunoprophylaxis after liver transplantation in HBsAg-positive patientsThe Lancet, 337
-
H. Wright, J. Gavaler, D. Theil (1992)
Preliminary experience with alpha-2b-interferon therapy of viral hepatitis in liver allograft recipients.Transplantation, 53 1
-
U. Hopf, Peter Neuhaus, H. Lobeck, V. König, S. Küther, J. Bauditz, W. Bechstein, G. Blumhardt, R. Steffen, R. Neuhaus, D. Huhn (1991)
Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon-alpha.Journal of hepatology, 13 3
-
M. Alter, H. Margolis, K. Krawczyński, F. Judson, A. Mares, W. Alexander, Pindiga Hu, Joan Miller, M. Gerber, R. Sampliner, Emory Meeks, M. Beach (1992)
The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.The New England journal of medicine, 327 27
-
Alter Alter, Margolis Margolis, Krawczynski Krawczynski, Judson Judson, Mares Mares, Alexander Alexander, Hu Hu (1992)
The natural history of community‐acquired hepatitis C in United StatesN Engl J Med, 327
-
C. Féray, M. Gigou, D. Samuel, V. Paradis, S. Mishiro, G. Maertens, M. Reynés, H. Okamoto, H. Bismuth, C. Bréchot, C. Bréchot (1995)
Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation.Gastroenterology, 108 4
-
C. Féray, D. Samuel, V. Thiers, M. Gigou, F. Pichon, A. Bismuth, M. Reynés, P. Maisonneuve, H. Bismuth, C. Bréchot (1992)
Reinfection of liver graft by hepatitis C virus after liver transplantation.The Journal of clinical investigation, 89 4
-
P. Scheuer, P. Ashrafzadeh, S. Sherlock, David Brown, G. Dusheiko (1992)
The pathology of hepatitis CHepatology, 15
-
H. Wright, J. Gavaler, D. Thiel (1992)
PRELIMINARY EXPERIENCE WITH α‐2b‐INTERFERON THERAPY OF VIRAL HEPATITIS IN LIVER ALLOGRAFT RECIPIENTS1,2Transplantation, 53
-
(1993)
Incidence and severity of liver allograft rejection following intitu-tion of alpha-interferon for the treatment of viral hepatitis in liver transplant recipients
- Publisher
- Wolters Kluwer Health
- Copyright
- Copyright © 1995 American Association for the Study of Liver Diseases
- ISSN
- 0270-9139
- eISSN
- 1527-3350
- DOI
- 10.1002/hep.1840220411
- Publisher site
- See Article on Publisher Site
Abstract
The aim of this open trial was to assess the efficacy and the safety of interferon (IFN) alfa therapy in liver transplant recipients with chronic active hepatitis caused by hepatitis C virus. In July 1991, among 447 liver recipients regularly observed at our institution, 46 had developed HCV‐related chronic active hepatitis defined by piece meal necrosis. Fourteen of these 46 patients received IFN alfa 3 mIU three times weekly for a planned duration of 6 months and were compared to the 32 untreated patients. Genotyping and quantification of viremia were performed using type‐specific amplification and branched DNA assay. Histological follow‐up was available in all patients and routinely before and after IFN therapy. Treated and untreated patients did not differ regarding gender, age, length of follow‐up, maximum histological score, and genotypes (41 of 46 were of type 1b). Induction of chronic rejection was observed in 5 of 14 treated patients leading to retransplantation in 3. In contrast, chronic rejection occurred in 1 of 32 untreated patients (P < .005) during the posttransplantation follow‐up. Among the 9 treated patients without rejection, a decrease of transaminases or of HCV RNA levels of more than 50% were observed in 8 and 4, respectively; 2 patients had a complete response, and 1 did not relapse after discontinuation of IFN. Histological improvement occurred in 2 of the treated patients and in none of the untreated patients. IFN therapy in liver transplant recipients has poor antiviral effect and can induce chronic rejection. Its use in this setting should be cautious. (HEPATOLOGY 1995; 22:1084–1089.).
Journal
Hepatology – Wolters Kluwer Health
Published: Oct 1, 1995